BIOTRONIK Excellence for Life

Heart disease is the leading cause of death among women worldwide. Yet, women’s heart health is too often overlooked.

This is why it’s time to put female cardiac care in the spotlight. At BIOTRONIK, we are united in advancing female cardiac care. Join us in our campaign to empower, educate, and lead the change for healthier hearts.

BIOTRONIK Neuro’s Prospera spinal cord stimulation (SCS) system treats patients suffering from chronic pain, helping them embrace life again. The system uniquely features:

• RESONANCE™, the first and only multiphase stimulation paradigm
• Embrace One, a truly first-of-its-kind ecosystem that provides automatic, objective, remote daily monitoring

_{Prospera SCS System is approved in the US only and is not available outside of the US.}

_{Note: Embrace One is a support platform intended to help manage a patient’s experience with spinal cord stimulation. It is not intended to be used for medical diagnosis or medical treatment.}

Working alongside physicians and listening closely to their needs, we have together developed a complete Conduction System Pacing (CSP) Solution, consisting of the world's first and only approved MR Conditional CSP system¹, comprehensive training, and expert technical support.

BIOTRONIK’s CSP system is composed of three proven components: 

• Selectra 3D – a broad range of optimally designed catheters delivering excellent handling²
• Solia S – the most popular choice of stylet-driven leads for LBBAP³, providing enhanced stability²
• Amvia – the first family of pacemakers approved for LBBAP.¹

With a collaboratively developed system and practical training programs, BIOTRONIK’s CSP Solution gives you the confidence and ease to undertake left bundle branch area pacing (LBBAP) approach.

BIOTRONIK’s latest insertable cardiac monitor, BIOMONITOR IV, comes with SmartECG, an intelligent system powered by artificial intelligence and advanced algorithms to provide actionable clinical insights.^1,2 

•Reduces 86% of false detections across all major arrhythmias³ 
•Streamlines ICM monitoring with intuitive templates and reports 
•The industry’s first to discriminate between PVCs and PACs^6,7 

Reduce your review burden and achieve timely and accurate diagnosis to focus on what’s most important – the patient.